SYT1-associated neurodevelopmental disorder: a case series

Broad Center for Mendelian Genomics

Research output: Contribution to journalArticle

Abstract

Synaptotagmin 1 (SYT1) is a critical mediator of fast, synchronous, calcium-dependent neurotransmitter release and also modulates synaptic vesicle endocytosis. This paper describes 11 patients with de novo heterozygous missense mutations in SYT1. All mutations alter highly conserved residues, and cluster in two regions of the SYT1 C2B domain at positions Met303 (M303K), Asp304 (D304G), Asp366 (D366E), Ile368 (I368T) and Asn371 (N371K). Phenotypic features include infantile hypotonia, congenital ophthalmic abnormalities, childhood-onset hyperkinetic movement disorders, motor stereotypies, and developmental delay varying in severity from moderate to profound. Behavioural characteristics include sleep disturbance and episodic agitation. Absence of epileptic seizures and normal orbitofrontal head circumference are important negative features. Structural MRI is unremarkable but EEG disturbance is universal, characterized by intermittent low frequency high amplitude oscillations. The functional impact of these five de novo SYT1 mutations has been assessed by expressing rat SYT1 protein containing the equivalent human variants in wild-type mouse primary hippocampal cultures. All mutant forms of SYT1 were expressed at levels approximately equal to endogenous wild-type protein, and correctly localized to nerve terminals at rest, except for SYT1M303K, which was expressed at a lower level and failed to localize at nerve terminals. Following stimulation, SYT1I368T and SYT1N371K relocalized to nerve terminals at least as efficiently as wild-type SYT1. However, SYT1D304G and SYT1D366E failed to relocalize to nerve terminals following stimulation, indicative of impairments in endocytic retrieval and trafficking of SYT1. In addition, the presence of SYT1 variants at nerve terminals induced a slowing of exocytic rate following sustained action potential stimulation. The extent of disturbance to synaptic vesicle kinetics is mirrored by the severity of the affected individuals' phenotypes, suggesting that the efficiency of SYT1-mediated neurotransmitter release is critical to cognitive development. In summary, de novo dominant SYT1 missense mutations are associated with a recognizable neurodevelopmental syndrome, and further cases can now be diagnosed based on clinical features, electrophysiological signature and mutation characteristics. Variation in phenotype severity may reflect mutation-specific impact on the diverse physiological functions of SYT1.

Original languageEnglish
Pages (from-to)2576-2591
Number of pages16
JournalBrain : a journal of neurology
Volume141
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Synaptotagmin I
Mutation
Synaptic Vesicles
Missense Mutation
Neurotransmitter Agents
Neurodevelopmental Disorders
Eye Abnormalities
Hyperkinesis
Phenotype
Absence Epilepsy
Muscle Hypotonia
Movement Disorders
Endocytosis
Action Potentials
Electroencephalography

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

SYT1-associated neurodevelopmental disorder : a case series. / Broad Center for Mendelian Genomics.

In: Brain : a journal of neurology, Vol. 141, No. 9, 01.09.2018, p. 2576-2591.

Research output: Contribution to journalArticle

Broad Center for Mendelian Genomics. / SYT1-associated neurodevelopmental disorder : a case series. In: Brain : a journal of neurology. 2018 ; Vol. 141, No. 9. pp. 2576-2591.
@article{e7b534483938419482a4c52cd1970e00,
title = "SYT1-associated neurodevelopmental disorder: a case series",
abstract = "Synaptotagmin 1 (SYT1) is a critical mediator of fast, synchronous, calcium-dependent neurotransmitter release and also modulates synaptic vesicle endocytosis. This paper describes 11 patients with de novo heterozygous missense mutations in SYT1. All mutations alter highly conserved residues, and cluster in two regions of the SYT1 C2B domain at positions Met303 (M303K), Asp304 (D304G), Asp366 (D366E), Ile368 (I368T) and Asn371 (N371K). Phenotypic features include infantile hypotonia, congenital ophthalmic abnormalities, childhood-onset hyperkinetic movement disorders, motor stereotypies, and developmental delay varying in severity from moderate to profound. Behavioural characteristics include sleep disturbance and episodic agitation. Absence of epileptic seizures and normal orbitofrontal head circumference are important negative features. Structural MRI is unremarkable but EEG disturbance is universal, characterized by intermittent low frequency high amplitude oscillations. The functional impact of these five de novo SYT1 mutations has been assessed by expressing rat SYT1 protein containing the equivalent human variants in wild-type mouse primary hippocampal cultures. All mutant forms of SYT1 were expressed at levels approximately equal to endogenous wild-type protein, and correctly localized to nerve terminals at rest, except for SYT1M303K, which was expressed at a lower level and failed to localize at nerve terminals. Following stimulation, SYT1I368T and SYT1N371K relocalized to nerve terminals at least as efficiently as wild-type SYT1. However, SYT1D304G and SYT1D366E failed to relocalize to nerve terminals following stimulation, indicative of impairments in endocytic retrieval and trafficking of SYT1. In addition, the presence of SYT1 variants at nerve terminals induced a slowing of exocytic rate following sustained action potential stimulation. The extent of disturbance to synaptic vesicle kinetics is mirrored by the severity of the affected individuals' phenotypes, suggesting that the efficiency of SYT1-mediated neurotransmitter release is critical to cognitive development. In summary, de novo dominant SYT1 missense mutations are associated with a recognizable neurodevelopmental syndrome, and further cases can now be diagnosed based on clinical features, electrophysiological signature and mutation characteristics. Variation in phenotype severity may reflect mutation-specific impact on the diverse physiological functions of SYT1.",
author = "{Broad Center for Mendelian Genomics} and Kate Baker and Gordon, {Sarah L.} and Holly Melland and Fabian Bumbak and Scott, {Daniel J.} and Jiang, {Tess J.} and David Owen and Turner, {Bradley J.} and Boyd, {Stewart G.} and Mari Rossi and Mohammed Al-Raqad and Orly Elpeleg and Dawn Peck and Mancini, {Grazia M.S.} and Martina Wilke and Marcella Zollino and Giuseppe Marangi and Heike Weigand and Ingo Borggraefe and Tobias Haack and Zornitza Stark and Simon Sadedin and Tan, {Tiong Yang} and Yunyun Jiang and Gibbs, {Richard A.} and Sara Ellingwood and Michelle Amaral and Whitley Kelley and Kurian, {Manju A.} and Cousin, {Michael A.} and Raymond, {F. Lucy}",
year = "2018",
month = "9",
day = "1",
doi = "10.1093/brain/awy209",
language = "English",
volume = "141",
pages = "2576--2591",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - SYT1-associated neurodevelopmental disorder

T2 - a case series

AU - Broad Center for Mendelian Genomics

AU - Baker, Kate

AU - Gordon, Sarah L.

AU - Melland, Holly

AU - Bumbak, Fabian

AU - Scott, Daniel J.

AU - Jiang, Tess J.

AU - Owen, David

AU - Turner, Bradley J.

AU - Boyd, Stewart G.

AU - Rossi, Mari

AU - Al-Raqad, Mohammed

AU - Elpeleg, Orly

AU - Peck, Dawn

AU - Mancini, Grazia M.S.

AU - Wilke, Martina

AU - Zollino, Marcella

AU - Marangi, Giuseppe

AU - Weigand, Heike

AU - Borggraefe, Ingo

AU - Haack, Tobias

AU - Stark, Zornitza

AU - Sadedin, Simon

AU - Tan, Tiong Yang

AU - Jiang, Yunyun

AU - Gibbs, Richard A.

AU - Ellingwood, Sara

AU - Amaral, Michelle

AU - Kelley, Whitley

AU - Kurian, Manju A.

AU - Cousin, Michael A.

AU - Raymond, F. Lucy

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Synaptotagmin 1 (SYT1) is a critical mediator of fast, synchronous, calcium-dependent neurotransmitter release and also modulates synaptic vesicle endocytosis. This paper describes 11 patients with de novo heterozygous missense mutations in SYT1. All mutations alter highly conserved residues, and cluster in two regions of the SYT1 C2B domain at positions Met303 (M303K), Asp304 (D304G), Asp366 (D366E), Ile368 (I368T) and Asn371 (N371K). Phenotypic features include infantile hypotonia, congenital ophthalmic abnormalities, childhood-onset hyperkinetic movement disorders, motor stereotypies, and developmental delay varying in severity from moderate to profound. Behavioural characteristics include sleep disturbance and episodic agitation. Absence of epileptic seizures and normal orbitofrontal head circumference are important negative features. Structural MRI is unremarkable but EEG disturbance is universal, characterized by intermittent low frequency high amplitude oscillations. The functional impact of these five de novo SYT1 mutations has been assessed by expressing rat SYT1 protein containing the equivalent human variants in wild-type mouse primary hippocampal cultures. All mutant forms of SYT1 were expressed at levels approximately equal to endogenous wild-type protein, and correctly localized to nerve terminals at rest, except for SYT1M303K, which was expressed at a lower level and failed to localize at nerve terminals. Following stimulation, SYT1I368T and SYT1N371K relocalized to nerve terminals at least as efficiently as wild-type SYT1. However, SYT1D304G and SYT1D366E failed to relocalize to nerve terminals following stimulation, indicative of impairments in endocytic retrieval and trafficking of SYT1. In addition, the presence of SYT1 variants at nerve terminals induced a slowing of exocytic rate following sustained action potential stimulation. The extent of disturbance to synaptic vesicle kinetics is mirrored by the severity of the affected individuals' phenotypes, suggesting that the efficiency of SYT1-mediated neurotransmitter release is critical to cognitive development. In summary, de novo dominant SYT1 missense mutations are associated with a recognizable neurodevelopmental syndrome, and further cases can now be diagnosed based on clinical features, electrophysiological signature and mutation characteristics. Variation in phenotype severity may reflect mutation-specific impact on the diverse physiological functions of SYT1.

AB - Synaptotagmin 1 (SYT1) is a critical mediator of fast, synchronous, calcium-dependent neurotransmitter release and also modulates synaptic vesicle endocytosis. This paper describes 11 patients with de novo heterozygous missense mutations in SYT1. All mutations alter highly conserved residues, and cluster in two regions of the SYT1 C2B domain at positions Met303 (M303K), Asp304 (D304G), Asp366 (D366E), Ile368 (I368T) and Asn371 (N371K). Phenotypic features include infantile hypotonia, congenital ophthalmic abnormalities, childhood-onset hyperkinetic movement disorders, motor stereotypies, and developmental delay varying in severity from moderate to profound. Behavioural characteristics include sleep disturbance and episodic agitation. Absence of epileptic seizures and normal orbitofrontal head circumference are important negative features. Structural MRI is unremarkable but EEG disturbance is universal, characterized by intermittent low frequency high amplitude oscillations. The functional impact of these five de novo SYT1 mutations has been assessed by expressing rat SYT1 protein containing the equivalent human variants in wild-type mouse primary hippocampal cultures. All mutant forms of SYT1 were expressed at levels approximately equal to endogenous wild-type protein, and correctly localized to nerve terminals at rest, except for SYT1M303K, which was expressed at a lower level and failed to localize at nerve terminals. Following stimulation, SYT1I368T and SYT1N371K relocalized to nerve terminals at least as efficiently as wild-type SYT1. However, SYT1D304G and SYT1D366E failed to relocalize to nerve terminals following stimulation, indicative of impairments in endocytic retrieval and trafficking of SYT1. In addition, the presence of SYT1 variants at nerve terminals induced a slowing of exocytic rate following sustained action potential stimulation. The extent of disturbance to synaptic vesicle kinetics is mirrored by the severity of the affected individuals' phenotypes, suggesting that the efficiency of SYT1-mediated neurotransmitter release is critical to cognitive development. In summary, de novo dominant SYT1 missense mutations are associated with a recognizable neurodevelopmental syndrome, and further cases can now be diagnosed based on clinical features, electrophysiological signature and mutation characteristics. Variation in phenotype severity may reflect mutation-specific impact on the diverse physiological functions of SYT1.

UR - http://www.scopus.com/inward/record.url?scp=85058731148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058731148&partnerID=8YFLogxK

U2 - 10.1093/brain/awy209

DO - 10.1093/brain/awy209

M3 - Article

C2 - 30107533

AN - SCOPUS:85058731148

VL - 141

SP - 2576

EP - 2591

JO - Brain

JF - Brain

SN - 0006-8950

IS - 9

ER -